Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
AI and Machine Learning in Urology: Current Uses and Future Directions
0
Zitationen
4
Autoren
2025
Jahr
Abstract
Background: Artificial Intelligence (AI) and Machine Learning (ML) have significantly transformed modern urology by enhancing diagnostic accuracy, surgical precision, and patient management. AI-driven innovations are increasingly integrated into urological practice, enabling early disease detection, predictive analytics, risk stratification, and robotic-assisted surgeries. This paper explores the current landscape of AI in urology, analyzing its applications in diagnostics, treatment planning, and surgical interventions. It highlights AI-driven technologies' benefits, challenges, and future research directions in optimizing patient care. Methods: A comprehensive literature review was conducted on AI applications in urology, examining studies on machine learning models—including deep learning and reinforcement learning—for detecting prostate, kidney, and bladder cancer, predictive analytics for disease progression, and AI-enhanced robotic surgeries. The analysis encompasses regulatory considerations, ethical implications (including data bias and patient privacy concerns), and real-world applications of AI in clinical settings. Results: AI performs superiorly in diagnostic imaging, histopathological analysis, and personalized treatment recommendations. Machine learning models enhance risk stratification, enabling more targeted therapeutic approaches. AI-driven robotic surgical systems enhance precision and reduce complications, while AI-powered remote monitoring tools optimize postoperative care. However, data bias, interpretability, regulatory constraints, and ethical concerns hinder widespread adoption. Conclusion: AI is revolutionizing urology by improving efficiency, accuracy, and patient outcomes. Future advancements in AI-driven precision medicine, autonomous robotic surgery, and AI-integrated telemedicine are promising. Addressing challenges related to data privacy, bias mitigation, and regulatory approval will be crucial for the seamless integration of AI into urological practice. Continued research and interdisciplinary collaboration will enhance AI's role in transforming urological healthcare.
Ähnliche Arbeiten
Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer
2004 · 5.698 Zit.
Decision Curve Analysis: A Novel Method for Evaluating Prediction Models
2006 · 5.120 Zit.
Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
2012 · 4.542 Zit.
Biochemical Outcome After Radical Prostatectomy, External Beam Radiation Therapy, or Interstitial Radiation Therapy for Clinically Localized Prostate Cancer
1998 · 4.488 Zit.
Screening and Prostate-Cancer Mortality in a Randomized European Study
2009 · 3.992 Zit.